{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T05:57:00Z","timestamp":1718258220962},"reference-count":26,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Das schmerzhafte \u201erote Auge\u201c ist wohl das auff\u00e4lligste Zeichen einer Augenerkrankung, hinter der milde, aber auch schwere Verl\u00e4ufe stecken k\u00f6nnen. Die Episkleritis und Skleritis sind\n          hierbei wichtige Differenzialdiagnosen. Die rechtzeitige Diagnose ist nicht nur wichtig f\u00fcr die notwendige Therapie, sondern kann vor einer irreversiblen Visusminderung, einem Augenverlust\n          sowie Organsch\u00e4den sch\u00fctzen und ggf. sogar das Mortalit\u00e4tsrisiko senken.<\/jats:p>","DOI":"10.1055\/a-2022-0689","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T23:46:55Z","timestamp":1677282415000},"page":"725-738","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostisches und therapeutisches Management der Episkleritis und Skleritis"],"prefix":"10.1055","volume":"240","author":[{"given":"Ferhat","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vita","family":"Dingerkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Tappeiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"108078","DOI":"10.1016\/j.exer.2020.108078","article-title":"Current insights in the pathogenesis of scleritis","volume":"197","author":"D PC Vergouwen","year":"2020","journal-title":"Exp Eye Res"},{"key":"ref2","first-page":"797","article-title":"[Diagnosis and treatment of episcleritis and scleritis]","volume":"113","author":"C Tappeiner","year":"2016","journal-title":"Ophthalmologe"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ceo.13761","article-title":"Epidemiology of episcleritis and scleritis in urban Australia","volume":"48","author":"L P Thong","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis subtypes in a german interdisciplinary uveitis center \u2013 analysis of 1916 patients","volume":"36","author":"E Jakob","year":"2009","journal-title":"J Rheumatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"P G Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.survophthal.2020.12.008","article-title":"The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review","volume":"66","author":"R E Ruiz-Lozano","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1442-9071.1991.tb00663.x","article-title":"Prediction of response to treatment in patients with scleritis using a standardised scoring system","volume":"19","author":"P McCluskey","year":"1991","journal-title":"Aust N Z J Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ophtha.2010.08.027","article-title":"A standardized grading system for scleritis","volume":"118","author":"H N Sen","year":"2011","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/ICL.0000000000000813","article-title":"Infectious scleritis: Pathophysiology, diagnosis, and management","volume":"47","author":"J Yu","year":"2021","journal-title":"Eye Contact Lens"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4103\/ijo.IJO_2032_20","article-title":"Scleritis: Differentiating infectious from non-infectious entities","volume":"68","author":"S I Murthy","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/art.41709","article-title":"Epidemiology of scleritis in the United Kingdom from 1997 to 2018: Population-based analysis of 11 million patients and association between scleritis and infectious and immune-mediated\n          inflammatory disease","volume":"73","author":"T Braithwaite","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/joco.joco_267_21","article-title":"B-Scan ultrasonography findings in unilateral posterior scleritis","volume":"34","author":"A Maleki","year":"2022","journal-title":"J Curr Ophthalmol"},{"key":"ref13","first-page":"1","article-title":"Clinical profile of scleritis presenting for the first time in the elderly","author":"K Magesan","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0161-6420(99)90157-4","article-title":"Severity of episcleritis and systemic disease association","volume":"106","author":"E K Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","article-title":"Therapy insight: scleritis and its relationship to systemic autoimmune disease","volume":"3","author":"J R Smith","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/09273940591004133","article-title":"Masquerade scleritis","volume":"13","author":"C Kafkala","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09273948.2015.1025983","article-title":"Imaging of the sclera in patients with scleritis and episcleritis using anterior segment optical coherence tomography","volume":"24","author":"S Axmann","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-6420(85)34074-5","article-title":"Anterior segment fluorescein angiography in the diagnosis of scleral inflammation","volume":"92","author":"P G Watson","year":"1985","journal-title":"Ophthalmology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0161-6420(98)93038-X","article-title":"Ultrasound biomicroscopy in scleritis","volume":"105","author":"A Heiligenhaus","year":"1998","journal-title":"Ophthalmology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1080\/09273948.2021.1966050","article-title":"Clinical relevance of autoantibodies and inflammatory parameters in non-infectious scleritis","volume":"30","author":"D PC Vergouwen","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ajo.2005.01.030","article-title":"Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis","volume":"139","author":"A M Bauer","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"D A Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/09273948.2015.1032308","article-title":"A nonselective cyclooxygenase (COX) inhibitor for treatment of noninfectious, non-necrotizing anterior scleritis","volume":"24","author":"R Agrawal","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.2009.164962","article-title":"Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis","volume":"94","author":"A Roufas","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ophtha.2011.02.043","article-title":"Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis","volume":"118","author":"E H Sohn","year":"2011","journal-title":"Ophthalmology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"J H Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2022-0689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T23:01:46Z","timestamp":1684537306000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2022-0689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":26,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2023,5,19]]},"published-print":{"date-parts":[[2023,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2022-0689","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]}}}